Full name: Jan Brandt - Jürgens
Current country: Germany
Membership level: Full
Type of membership: Member
Number of publications: 10
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial (2024)
https://pubmed.ncbi.nlm.nih.gov/38228361/
Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/35368376/
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab (2022)
https://pubmed.ncbi.nlm.nih.gov/35674938/
Successful Evaluation of Spinal Mobility Measurements With the Epionics SPINE Device in Patients With Axial Spondyloarthritis Compared to Controls (2021)
https://pubmed.ncbi.nlm.nih.gov/34393107/
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32378070/
Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30418704/
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. (2016)
https://pubmed.ncbi.nlm.nih.gov/26865599/
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety (2016)
https://pubmed.ncbi.nlm.nih.gov/27049733/
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. (2016)
https://pubmed.ncbi.nlm.nih.gov/26865599/